Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy
Status:
Completed
Trial end date:
2020-02-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of allogeneic hematopoietic stem cell
transplantation (allo-HSCT) from matched sibling donor (MSD),matched unrelated donor (MUD)
and haploidentical related donors(HRD) in the treatment of hematologic malignancy.
Phase:
N/A
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
First Affiliated Hospital of Guangxi Medical University Fujian Medical University Fujian Medical University Union Hospital Guangdong General Hospital Guangdong Provincial People's Hospital Guangxi Medical University Guangzhou First Municipal People’s Hospital Guangzhou First People's Hospital Guangzhou General Hospital of Guangzhou Military Command Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Third Affiliated Hospital, Sun Yat-Sen University Tongji Hospital Wuhan Union Hospital, China Xiangya Hospital of Central South University Zhujiang Hospital